The UK has launched its first pilot vaccination programme against gonorrhea, initially targeting pre-teen and teenage groups in areas with high rates of infection.

Health officials say the initiative marks a major step toward addressing rising antibiotic resistance in sexually transmitted infections by preventing cases before they require treatment.

The vaccine, developed from research on outer membrane vesicles, will be evaluated over multiple years for safety and effectiveness before any wider rollout.